Clinical Trial Update: A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lansoprazole to prevent aspirin-induced gastric and duodenal ulcers was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Takeda | Conditions: Stomach Ulcer, Duodenal Ulcer | Phase 3 | Status: TERMINATED | Results posted: 2011-05-10